164 results
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
retention guidelines Neutralize share buyback impact on share-denominated compensation metrics Robust recoupment and clawback policies Regular … , medium and long-term performance periods Multi-year vesting helps to promote retention while maintaining pay-for-performance link Long-Term Incentive
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
18 Mar 24
Strengthening Neuroscience Portfolio
8:56am
partners and competitors to the consummation of the transaction and/or potential difficulties in employee retention as a result of the consummation
SC TO-T/A
EX-99
RYZB
RayzeBio Inc.
23 Feb 24
Third party tender offer statement (amended)
7:34am
to the consummation of the proposed transaction and/or potential difficulties in employee retention as a result of the consummation of the proposed transaction
8-K
EX-1.1
28fobo7
22 Feb 24
Other Events
4:15pm
424B5
bgq2eheq3tkwascwt9g
16 Feb 24
Prospectus supplement for primary offering
4:34pm
424B2
jba3l
13 Feb 24
Prospectus for primary offering
8:00am
SC TO-T/A
EX-99
vqqhdd0
12 Feb 24
Third party tender offer statement (amended)
7:34am
SC TO-T
EX-99
t5egx
25 Jan 24
Third party tender offer statement
8:13am
SC TO-C
EX-99.2
9w12m13 k3z57
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.5
de9ey eb3o5mb838u
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.3
orbad9wl6aff7 hq
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
d34n3g3p
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.1
88v 5zgske
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.4
8f87 2w63267
26 Dec 23
Information about tender offer
4:22pm
DFAN14A
7vrz 2dv6z
22 Dec 23
Additional proxy materials by non-management
4:36pm
DFAN14A
fks3dl795u32y r5pu05
22 Dec 23
Additional proxy materials by non-management
4:21pm
DFAN14A
EX-99.1
q6hbitpg 32cg
22 Dec 23
Additional proxy materials by non-management
4:21pm